C B A / N mice, a m u t a n t subline of the C B A / C a strain, have an X-linked B l y m p h o c y t e -i m m u n e defect. These mice and F1 male progeny derived from C B A / N females fail to produce specific a n t i b o d y after i m m u n i z a t i o n with certain thymicindependent (TI) antigens (1-4). In addition, these mice fail to produce I g M or IgG responses to either the T I or T -d e p e n d e n t derivatives of the hapten phosphorylcholine (PC) (5, 6). Moreover, analysis of surface m e m b r a n e characteristics indicates that B cells derived from i m m u n e defective mice fail to express determinants that are present on a population of B lymphocytes that appears late in ontogeny. These include minor lymphocyte-stimulating determinants (7), Lyb5 (8), and Lyb3 (9). Furthermore, the B cells of C B A / N mice have unusually high amounts of surface I g M (sIgM) and exhibit a low ratio of surface 8:/~ heavy chains when c o m p a r e d with the B cells of normal mice (10, 11). These surface characteristics are similar to those that are exhibited by neonatal B cells (10). T a k e n together, these findings are consistent with the hypothesis that the i m m u n e defect(s) in C B A / N mice arise from a m a t u r a t i o n a l arrest either in the development of C B A / N B cells or of a subpopulation of these B cells.Previous studies, which used a modification of the in vitro splenic focus technique (12), have suggested that susceptibility to in vitro tolerance induction m a y serve as a functional marker for developing (immature) B cells and B-cell m a t u r a t i o n (12-14). This conclusion is based primarily on the following observations. (a) 2,4-dinitrophenyl (DNP)-and PC-reactive splenic B cells are tolerizable only for the first few days after their initial expression in the murine neonate (12, 13). (b) Neonatal bone marrow B cells can be rendered unresponsive to antigen longer in development than neonatal splenic B cells (13,14). (c) Whereas adult splenic B cells are not susceptible to in vitro tolerance induction, 25% of adult bone marrow B cells are tolerizable (13,14).